Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction

Tomoko Inoue, Keiji Matsunaga, Waki Kobayashi,Tetsuo Minamino

Clinical Case Reports(2023)

引用 0|浏览1
暂无评分
摘要
Abstract Ivabradine is an established treatment for chronic heart failure with reduced ejection fraction (HFrEF); however, it is not used for acute heart failure treatment. Negative inotropic effects (NIE) often limit the up‐titration of β‐blockers. Contrarily, ivabradine has no NIE, and enables β‐blockers usage for treating patients with acute decompensated HFrEF.
更多
查看译文
关键词
acute decompensated heart failure,cancer therapy‐related cardiac dysfunction,inappropriate tachycardia,ivabradine,up‐titration,β‐Blocker
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要